Hazard ratio* of CVD and 95% confidence intervals by mother's age of onset of MI in men and women aged 40–65 years.

<p>* HR adjusted for age and father's age of onset of MI.</p

Baseline characteristics^* and observed percentage of CVD^** in 4878 men and 5646 women by parental MI in the MORGEN-cohort.

<p>*Data are presented as mean, SD or %.</p><p>**CVD events during an average follow-up of 10 years.</p><p>BMI, body mass index; HDL, high density lipoproteïn; MI, myocardial infarction; CVD, cardiovascular diseases.</p

Hazard ratio* of CVD and 95% confidence intervals by parental age of onset of MI in respondents aged 40–65 years.

<p>* HR adjusted for age and gender.</p

CHD mortality rates 1997 and 2007 by sex and socioeconomic group.

<p>CHD mortality rates 1997 and 2007 by sex and socioeconomic group.</p

Deaths Prevented or Postponed (DPPs) due to changes in risk factors for coronary heart disease <i>including the effect of changes in primary prevention treatments</i> between 1997 and 2007.

<p>Deaths Prevented or Postponed (DPPs) due to changes in risk factors for coronary heart disease <i>including the effect of changes in primary prevention treatments</i> between 1997 and 2007.</p

Proportion of CHD deaths prevented or postponed by socioeconomic group, due to change in treatments and risk factors between 1997 and 2007.

<p>Proportion of CHD deaths prevented or postponed by socioeconomic group, due to change in treatments and risk factors between 1997 and 2007.</p

Percentage of the decrease in deaths from coronary heart disease attributed to changes in acute phase and secondary prevention treatments, primary prevention treatments and non-pharmacological risk factor changes in our study population and in other populations.

<p>Studies are ranked by starting year.</p